Lotus Pharmaceuticals Pink Sheet Forecast - Simple Moving Average
| LTUS Stock | USD 0 0.0002 5.13% |
The Simple Moving Average forecasted value of Lotus Pharmaceuticals on the next trading day is expected to be 0 with a mean absolute deviation of 0.0004 and the sum of the absolute errors of 0.02. Lotus Pink Sheet Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of Lotus Pharmaceuticals' share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Lotus Pharmaceuticals hype-based prediction, you can estimate the value of Lotus Pharmaceuticals from the perspective of Lotus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Lotus Pharmaceuticals on the next trading day is expected to be 0 with a mean absolute deviation of 0.0004 and the sum of the absolute errors of 0.02. Lotus Pharmaceuticals after-hype prediction price | USD 0.002249 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lotus |
Lotus Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Lotus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lotus using various technical indicators. When you analyze Lotus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Lotus Pharmaceuticals Simple Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Lotus Pharmaceuticals on the next trading day is expected to be 0 with a mean absolute deviation of 0.0004, mean absolute percentage error of 0.00000048, and the sum of the absolute errors of 0.02.Please note that although there have been many attempts to predict Lotus Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Lotus Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Lotus Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Lotus Pharmaceuticals | Lotus Pharmaceuticals Price Prediction | Buy or Sell Advice |
Lotus Pharmaceuticals Forecasted Value
In the context of forecasting Lotus Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Lotus Pharmaceuticals' downside and upside margins for the forecasting period are 0.000037 and 18.87, respectively. We have considered Lotus Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Lotus Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Lotus Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.8935 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 4.0E-4 |
| MAPE | Mean absolute percentage error | 0.0899 |
| SAE | Sum of the absolute errors | 0.0226 |
Predictive Modules for Lotus Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lotus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lotus Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lotus Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Lotus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lotus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Lotus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lotus Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Lotus Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lotus Pharmaceuticals' historical news coverage. Lotus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 18.87, respectively. We have considered Lotus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lotus Pharmaceuticals is out of control at this time. Analysis and calculation of next after-hype price of Lotus Pharmaceuticals is based on 3 months time horizon.
Lotus Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lotus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lotus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lotus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.55 | 18.87 | 0.01 | 0.01 | 3 Events / Month | 1 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 39.22 |
|
Lotus Pharmaceuticals Hype Timeline
Lotus Pharmaceuticals is now traded for 0. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Lotus is anticipated to decline in value after the next headline, with the price expected to drop to 0.002249. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -39.22%, whereas the daily expected return is now at 1.55%. The volatility of related hype on Lotus Pharmaceuticals is about 348798.52%, with the expected price after the next announcement by competition of -0.01. The company has price-to-book ratio of 0.01. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lotus Pharmaceuticals had not issued any dividends in recent years. The entity had 1:2 split on the 31st of December 2010. Given the investment horizon of 90 days the next anticipated press release will be in about 3 days. Check out Historical Fundamental Analysis of Lotus Pharmaceuticals to cross-verify your projections.Lotus Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Lotus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Lotus Pharmaceuticals' future price movements. Getting to know how Lotus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lotus Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CDSG | China Dongsheng International | 0.00 | 0 per month | 14.98 | 0.09 | 30.00 | (25.00) | 122.12 | |
| ALDA | Atlantica | 0.00 | 4 per month | 0.00 | 0.10 | 0.00 | 0.00 | 42.86 | |
| AWON | A1 Group | (0) | 2 per month | 11.61 | 0.02 | 30.00 | (23.53) | 85.06 | |
| VNTA | Ventana Biotech | (0.05) | 1 per month | 0.00 | (0.07) | 0.27 | (20.21) | 75.82 | |
| AAPT | All American Pet | (0) | 4 per month | 0.00 | 0.12 | 0.00 | 0.00 | 2,995 | |
| MNZO | Manzo Pharmaceut | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HBIE | Hai Jia International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CHMJF | Chemistree Technology | 0.00 | 0 per month | 0.00 | 0.21 | 24.00 | 0.00 | 96.20 | |
| MYRX | Myrexis Cmn Stk | 0.00 | 0 per month | 0.00 | 0.11 | 0.00 | 0.00 | 300.00 | |
| AWWI | Alpha Wastewater | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Lotus Pharmaceuticals
For every potential investor in Lotus, whether a beginner or expert, Lotus Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lotus Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lotus. Basic forecasting techniques help filter out the noise by identifying Lotus Pharmaceuticals' price trends.Lotus Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lotus Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Lotus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Lotus Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lotus Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Lotus Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lotus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Lotus Pharmaceuticals pink sheet market strength indicators, traders can identify Lotus Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 0.0037 | |||
| Day Typical Price | 0.0037 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0002) |
Lotus Pharmaceuticals Risk Indicators
The analysis of Lotus Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lotus Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lotus pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.7 | |||
| Semi Deviation | 10.46 | |||
| Standard Deviation | 18.23 | |||
| Variance | 332.35 | |||
| Downside Variance | 552.59 | |||
| Semi Variance | 109.35 | |||
| Expected Short fall | (29.87) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lotus Pharmaceuticals
The number of cover stories for Lotus Pharmaceuticals depends on current market conditions and Lotus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lotus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lotus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.